Fasenra recalls
Fasenra products have been recalled 1 time, most recently on 22 Oct 2025. The recalling company is usually Astrazeneca Pharmaceuticals. The most common reason is sterility.
Total recalls1since 2025
Last 12 months1reported
Class I00% of total
Ongoing1latest 22 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why fasenra is recalled
Companies
Product types
By year
Ongoing fasenra recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fasenra (benralizumab) Injection, 30 mg/mL recalledFasenra | Astrazeneca Pharmaceuticals | Sterility | Nationwide |
All fasenra recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fasenra (benralizumab) Injection, 30 mg/mL recalledFasenra | Astrazeneca Pharmaceuticals | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.